Research identifies key factors in initiating tumor dormancy

A new research paper was published in Oncotarget’s Volume 15 on October 11, 2024, entitled “Initiation of tumor dormancy by the lymphovascular embolus.”

H1 Expands Trial Landscape Platform with UK Diversity Data and AI-Powered Site Rescue

What You Should Know: – H1, a provider of healthcare data and analytics, has announced significant enhancements to its Trial Landscape platform. – These updates

October 31, 2024

Biogen CEO sees Alzheimer’s drug on right path despite tiny sales, will keep biosimilars business

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

August 2, 2024

ActiTrexx treats first patient with novel regulatory T cell therapy against Graft-versus-Host Disease – Biotech Investments

EQS-News: ActiTrexx GmbH / Key word(s): Study ActiTrexx treats first patient with novel regulatory T cell therapy against Graft-versus-Host Disease 19.03.2024 / 10:00 CET/CEST The

March 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.